Free Trial

IMAC Q4 2022 Earnings Report

IMAC logo
$0.05 +0.00 (+7.45%)
As of 11:50 AM Eastern

IMAC EPS Results

Actual EPS
-$2.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

IMAC Revenue Results

Actual Revenue
$3.47 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

IMAC Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Remove Ads

IMAC Earnings Headlines

Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
See More IMAC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IMAC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IMAC and other key companies, straight to your email.

About IMAC

IMAC (NASDAQ:BACK) owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.

View IMAC Profile

More Earnings Resources from MarketBeat